AbCellera Biologics (ABCL) Debt Ratio (2020 - 2025)

AbCellera Biologics (ABCL) has 6 years of Debt Ratio data on file, last reported at 0.01 in Q1 2025.

• Quarterly Debt Ratio fell 81.44% year-over-year to 0.01 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 0.01 (down 81.44% YoY) and the FY2024 annual result came in at 0.01, down 82.48% from the prior year.
• Debt Ratio rose to 0.01 in Q1 2025, from 0.01 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.04 in Q2 2023 to a low of 0.01 in Q4 2024.
• A 5-year average of 0.02 and a median of 0.02 in 2021 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2022 — Debt Ratio surged 113.92% — and 2024, when it slumped 82.48%.
• Tracing ABCL's Debt Ratio over 5 years: stood at 0.02 in 2021, then jumped by 64.96% to 0.03 in 2022, then rose by 18.22% to 0.03 in 2023, then slumped by 82.48% to 0.01 in 2024, then climbed by 9.78% to 0.01 in 2025.
• The last three Debt Ratio figures came in at 0.01 (Q1 2025), 0.01 (Q4 2024), and 0.01 (Q3 2024), per Business Quant data.